When.com Web Search

  1. Ads

    related to: drugs that cause macular damage treatment for macular degeneration wet amd treatment

Search results

  1. Results From The WOW.Com Content Network
  2. Macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Macular_degeneration

    Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. [1] Early on there are often no symptoms. [1] Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. [1]

  3. Intravitreal injection - Wikipedia

    en.wikipedia.org/wiki/Intravitreal_injection

    At the end of the year, on December 17, the first intravitreal anti-VEGF drug pegaptanib (Macugen) was also licensed by FDA for treatment of wet age-related macular degeneration (wet AMD). [2] [9] Intravitreal injection has then become more common and a surge in the number of injections performed could be seen. [10]

  4. Ranibizumab - Wikipedia

    en.wikipedia.org/wiki/Ranibizumab

    Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment created from the same parent mouse antibody as bevacizumab.It is an anti-angiogenic [16] that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion.

  5. Anti-VEGF - Wikipedia

    en.wikipedia.org/wiki/Anti-VEGF

    Ranibizumab, a monoclonal antibody fragment (Fab) derived from bevacizumab, has been developed by Genentech for intraocular use.In 2006, FDA approved the drug for the treatment of neovascular age-related macular degeneration (wet AMD).

  6. Macular edema - Wikipedia

    en.wikipedia.org/wiki/Macular_edema

    The causes of macular edema are numerous and different causes may be inter-related. It is commonly associated with diabetes.Chronic or uncontrolled diabetes type 2 can affect peripheral blood vessels including those of the retina which may leak fluid, blood and occasionally fats into the retina causing it to swell.

  7. Opthea Announces Publication in Diabetic Macular Edema

    lite.aol.com/tech/story/0022/20250107/9327494.htm

    Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to address the unmet needs in the treatment of highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).

  1. Ad

    related to: drugs that cause macular damage treatment for macular degeneration wet amd treatment